ArticleAnnals of surgical treatment and research2025

Predicting prognosis and optimal timing for surgery using CA 19-9 in patients with pancreatic cancer who underwent FOLFIRINOX-based neoadjuvant therapy: a retrospective single-center cohort study.

Hochang Chae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.